Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type-I Interferon Signaling in Fanconi Anemia. | Front Cell Infect Microbiol | 2022 | 35198459 | PubTator, text mining | PubMed |
| Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging. | Neuroimage | 2022 | 35196565 | PubTator, text mining | PubMed |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. | JAMA Netw Open | 2022 | 35171259 | PubTator, text mining | PubMed |
| Structural Analysis of Human Serum Albumin in Complex with the Fibrate Drug Gemfibrozil. | Int J Mol Sci | 2022 | 35163693 | PubTator, text mining | PubMed |
| Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. | Int J Mol Sci | 2022 | 35163129 | PubTator, text mining | PubMed |
| PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers. | Cancers (Basel) | 2022 | 35158866 | PubTator, text mining | PubMed |
| SCAI promotes error-free repair of DNA interstrand crosslinks via the Fanconi anemia pathway. | EMBO Rep | 2022 | 35156773 | PubTator, text mining | PubMed |
| Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky. | Proc Jpn Acad Ser B Phys Biol Sci | 2022 | 35153270 | PubTator, text mining | PubMed |
| Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer. | Nat Commun | 2022 | 35149709 | PubTator, text mining | PubMed |
| Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. | Nat Biotechnol | 2022 | 35145312 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| A functional genomic approach to actionable gene fusions for precision oncology. | Sci Adv | 2022 | 35138907 | PubTator, text mining | PubMed |
| Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients. | Clin Med Insights Oncol | 2022 | 35110966 | PubTator, text mining | PubMed |
| Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. | BMC Cancer | 2022 | 35109796 | PubTator, text mining | PubMed |
| Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma. | Ann Gastroenterol Surg | 2022 | 35106410 | PubTator, text mining | PubMed |
| Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer. | Clin Cancer Res | 2022 | 35091441 | PubTator, text mining | PubMed |
| Multi attribute method implementation using a High Resolution Mass Spectrometry platform: From sample preparation to batch analysis. | PLoS One | 2022 | 35085302 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| Changes in Glycated Human Serum Albumin Binding Affinity for Losartan in the Presence of Fatty Acids In Vitro Spectroscopic Analysis. | Molecules | 2022 | 35056715 | PubTator, text mining | PubMed |
| Excited States Computation of Models of Phenylalanine Protein Chains: TD-DFT and Composite CC2/TD-DFT Protocols. | Int J Mol Sci | 2022 | 35054802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=31